ADAPTIVE BIOTECHNOLOGIES CORPORATION Earnings Per Share (Diluted)
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Earnings Per Share (Diluted) of -$0.25 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION earnings per share, diluted for the quarter ending 2026-06-30 was -$0.25.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION earnings per share, diluted for the quarter ending 2026-03-31 was -$0.13.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION earnings per share, diluted for the quarter ending 2025-12-31 was -$0.09.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION earnings per share, diluted for the quarter ending 2025-09-30 was $0.06.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION earnings per share, diluted for fiscal 2025 was -$0.39.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION earnings per share, diluted for fiscal 2024 was -$1.08.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION earnings per share, diluted for fiscal 2023 was -$1.56.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION earnings per share, diluted for fiscal 2022 was -$1.40.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.25 10-Q · filed 2026-08-04 | -$0.38 10-Q · filed 2026-08-04 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2026-03-31 | -$0.13 10-Q · filed 2026-05-05 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.39 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.06 10-Q · filed 2025-11-05 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.30 10-Q · filed 2025-11-05 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-06-30 | -$0.17 10-Q · filed 2026-08-04 | -$0.37 10-Q · filed 2026-08-04 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-03-31 | -$0.20 10-Q · filed 2026-05-05 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-05-05 |
| 2024-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.08 10-K · filed 2026-02-26 |
| 2024-09-30 | -$0.22 10-Q · filed 2025-11-05 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.86 10-Q · filed 2025-11-05 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-06-30 | -$0.31 10-Q · filed 2025-08-05 | -$0.64 10-Q · filed 2025-08-05 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-03-31 | -$0.33 10-Q · filed 2025-05-01 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2023-12-31 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.56 10-K · filed 2026-02-26 |
| 2023-09-30 | -$0.35 10-Q · filed 2024-11-07 | -$0.68 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.08 10-Q · filed 2024-11-07 | -$1.36 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2023-06-30 | -$0.33 10-Q · filed 2024-08-01 | -$0.73 10-Q · filed 2024-08-01 | -$1.01 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.33 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-07 | -$0.68 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.00 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2022-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$0.60 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$0.96 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.40 10-K · filed 2025-03-03 |
| 2022-09-30 | -$0.32 10-Q · filed 2023-11-09 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.12 10-Q · filed 2023-11-09 | -$1.56 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2022-06-30 | -$0.37 10-Q · filed 2023-08-02 | -$0.81 10-Q · filed 2023-08-02 | -$1.24 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.64 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2022-03-31 | -$0.44 10-Q · filed 2023-05-03 | -$0.88 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.27 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.63 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2021-12-31 | -$0.43 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$0.83 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.18 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.48 10-K · filed 2024-02-29 |
| 2021-09-30 | -$0.40 10-Q · filed 2022-11-03 | -$0.75 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.04 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$0.35 10-Q · filed 2022-08-03 | -$0.64 10-Q · filed 2022-08-03 | ||
| 2020-12-31 | -$1.11 10-K · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |